Showing results (41-50 of 122) with videos related to

Sort By:
Pageof 13
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|December 4, 2012
Prognostic factors in patients with non resectable metastatic colorectal cancer in the era of targeted biotherapies: relevance of Köhne's risk classificationElise Desot, Louis de Mestier, Julien Volet, et al.
Neuroendocrinology|August 14, 2017
Digestive System Mixed Neuroendocrine-Non-Neuroendocrine NeoplasmsLouis de Mestier, Jérôme Cros, Cindy Neuzillet, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|June 6, 2021
Efficacy and tolerance of gemcitabine and nab-paclitaxel in elderly patients with advanced pancreatic ductal adenocarcinomaFlore Pignon, Anthony Turpin, Olivia Hentic, et al.
The Journal of Pathology|December 19, 2025
Molecular alterations in high-grade neuroendocrine tumors of the small intestineAgathe Hercent, Julien Masliah-Planchon, David Cohen, et al.
Cancer Investigation|June 30, 2016
Impact of Visceral Obesity on Microvascular Invasion in Hepatocellular CarcinomaNicolae Arsenii, Tullio Piardi, Marie-Danièle Diébold, et al.
Therapeutic Advances in Medical Oncology|July 23, 2020
Maintenance therapies in metastatic pancreatic cancer: present and future with a focus on PARP inhibitorsPascal Hammel, Carole Vitellius, Émeric Boisteau, et al.
Annals of Surgery|August 1, 2025
Defining Biological Borderline Resectable Non-Functioning Pancreatic Neuroendocrine Tumors (NF-PanNETs): A Predictive Model for Preoperative Assessment of Early Recurrence RiskStefano Partelli, Giovanni Guarneri, Paola Mv Rancoita, et al.
World Journal of Gastroenterology|September 28, 2019
Role of endoscopic ultrasound in the screening and follow-up of high-risk individuals for familial pancreatic cancerDiane Lorenzo, Vinciane Rebours, Frédérique Maire, et al.
Annals of Surgical Oncology|October 9, 2023
The Need for Centralization for Small Intestinal Neuroendocrine Tumor Surgery: A Cohort Study from the GTE-Endocan-RENATEN Network, the CentralChirSINET StudyMaroin Kalifi, Sophie Deguelte, Matthieu Faron, et al.
Expert Review of Anticancer Therapy|September 16, 2020
PARP inhibition in treatment of pancreatic cancerPascal Hammel, Chen Zhang, Julia Matile, et al.
Pageof 13